ProQR's Annual General Meeting (AGM) of Shareholders will take place on Wednesday, May 22, 2024 at 1630 CET (10:30am EDT) at the offices of Allen & Overy LLP, in Amsterdam, the Netherlands.
The 2021 annual general meeting (AGM) of shareholders of ProQR Therapeutics
will take place on Wednesday, May 19, 2021, at 16:00 hours CET/10:00am EDT.
Annual General Meeting of Shareholders to be held on June 30, 2022René Beukema joins management team as Chief Corporate Development Officer and General Counsel and is nominated to Management BoardGerard Platenburg to assume Chief Scientific Officer role, with le
… ProQR Announces AnnualMeeting of Shareholders LEIDEN, Netherlands & CAMBRIDGE, … retinal diseases (IRDs), today announced the AnnualGeneralMeeting of Shareholders will take place on Wednesday, …
… ProQR Nominates Martin Maier, PhD to Board and Announces AnnualMeeting of Shareholders to be Held May 22, 2024 LEIDEN, … editing technology platform, today announced the AnnualGeneralMeeting (AGM) of Shareholders will take place on …
Development of Axiomer® RNA base editing technology platform continues across multiple therapeutic areas; initial pipeline targets to be disclosed in early 2023 with Analyst and Investor R&D event to be held in Q1 2023
Management Team appointments and p